Type 1 Diabetes: Primary Prevention Therapeutic Programs and First Pre-Autoantibody Biomarker Based on Association Between Autoimmunity and Dynamics of Amyloid-Producing E.coli

Human Microbiology Institute research the first propose the concept of novel cause of Type 1 Diabetes development. In this study we discovered the effect of certain  gut bacteria and bacteriophages on triggering autoimmunity and  seroconversion in HLA-susceptible children.

 Research Will Be Presented at 5^th Annual Translational Microbiome Conference (https://www.microbiomeconference.com/ )